Upgrade to SI Premium - Free Trial

Rafael Holdings (RFL)

2.56 +0.09 (3.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/30/26 *Est.)

Latest Headlines

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage August 10, 2026 9:01 AM - StreetInsider Form 4 Rafael Holdings, Inc. For: Jul 29 Filed by: JONAS HOWARD S July 31, 2026 4:55 PM - SEC Filing Form 8-K Rafael Holdings, Inc. For: Jul 08 July 8, 2026 4:46 PM - SEC Filing Form 4 Rafael Holdings, Inc. For: Jun 21 Filed by: Polinsky David June 23, 2026 3:33 PM - SEC Filing Form 4 Rafael Holdings, Inc. For: Jun 13 Filed by: JONAS HOWARD S June 16, 2026 3:55 PM - SEC Filing Form 10-Q Rafael Holdings, Inc. For: Apr 30 June 11, 2026 8:18 AM - SEC Filing Form 8-K Rafael Holdings, Inc. For: Jun 11 June 11, 2026 7:55 AM - SEC Filing Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results June 11, 2026 7:30 AM - StreetInsider Form 8-K Rafael Holdings, Inc. For: Jun 10 June 10, 2026 7:49 AM - SEC Filing Rafael Holdings completes phase 3 study for rare disease treatment June 10, 2026 7:30 AM - StreetInsider Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C June 10, 2026 7:30 AM - StreetInsider Full Article List